Mistletoe Extract Benefits Pancreatic Cancer Patients
December 2014
Print

Natural Alternative Increases Survival Rate

mistletoeA study published in the European Journal of Cancer revealed that a mistletoe extract may lengthen life for patients with severe pancreatic cancer. German researchers tested 220 patients with advanced stage pancreatic cancer, an aggressive, often fatal disease. The patients were divided into two groups; one was given up to 10 milligrams of Viscum album (European mistletoe) three times a week for up to 12 months. Both groups received supportive care throughout the study period.

The average length of survival for those taking the mistletoe extract, 4.8 months, was nearly twice that of the other group, 2.7 months; a survival period typically dates from the original diagnosis. Within a group considered to have a good prognosis, the survival period for those that consumed the extract, averaging 6.6 months, was more than double that of the no-extract group, which averaged 3.2 months.